Hilma Nandrolone Decanoate 10 ml/250 mg



Company: Hilma Biocare
Active Half-life (Days): 15 days
Group: Anabolic Steroids
Subgroup: Injection
Dosage: 250 mg/ml
Application (Men): 250-750 mg a week
Product pack: 10ml vial
Content (active): Nandrolone Decanoate
Oil-based: Yes
Retains water: Yes
Aromatization: No

Product Description

Firstly, introduced in the distant 1960, Nandrolone Decanoate became one of the best known anabolic steroids around the globe. Nandrolone Decanoate or 19 Nortestosterone has a similar structural composition to testosterone but without a carbon atom at the 19th position. As a result, it binds to progestin receptors after admission to the body. Nandrolone Decanoate is considered among the strongest body-building and performance-enhancing steroids on the market.


Using Nandrolone Decanoate, athletes can increase lean muscle gains, boost strength, and lift oxygen in the blood cells to stimulate faster body regeneration. Additionally, it serves as a mind pain killer in ligament areas and joints.


The most common adverse reactions attributed to the Nandrolone Decanoate are acne, temporary testosterone reproduction shutdown, raised Low-density cholesterol levels (LDL), increased prolactin level, potency (high doses).


When using this product, consider the inclusion of bromocriptine, cabergoline and gonadotropin to minimize side effects.


Nandrolone Decanoate shows excellent results and can be safely applied with long esters and HGH.

Avoid the consumption of Tamoxifen, Trenbolone or Oxymetholone when using Nandrolone Decanoate.


Hilma Biocare

1 review for Hilma Nandrolone Decanoate 10 ml/250 mg

  1. sportanabolic

    Label claim: Hilma Biocare Nandrolone Decanoate has a label claim of 250 mg/ml nandrolone decanoate.

    Actual content: Hilma Biocare Nandrolone Decanoate was determined to have an actual content of 245 mg/ml nandrolone decanoate.

    Microbiological contamination was detected. No yeast or mold contamination was detected.


Add a review

Your email address will not be published.